Literature DB >> 70714

Monoamine-oxidase inhibitors and prolactin secretion.

J Mendlewicz, M B Youdim.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 70714     DOI： 10.1016/s0140-6736(77)91632-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO "type B" inhibitor.

Authors:  J Mendlewicz; M B Youdim
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

3.  Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man.

Authors:  M Strolin Benedetti; A Eschalier; A Lesage; G Dordain; V Rovei; E Zarifian; P Dostert
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.